Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.
Saved in:
| Title: | Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. |
|---|---|
| Authors: | Stasik S; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany., Burkhard-Meier C; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Kramer M; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Middeke JM; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Oelschlaegel U; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Sockel K; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Ehninger G; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Serve H; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany., Müller-Tidow C; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Baldus CD; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Röllig C; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Bornhäuser M; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany., Platzbecker U; Department of Hematology, Cellular Therapy, and Hemostaseology, University Hospital Leipzig, Leipzig, Germany; and., Thiede C; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; AgenDix GmbH, Dresden, Germany. |
| Source: | Blood advances [Blood Adv] 2022 Jun 14; Vol. 6 (11), pp. 3294-3303. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35320339 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stasik+S%22">Stasik S</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Burkhard-Meier+C%22">Burkhard-Meier C</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kramer+M%22">Kramer M</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Middeke+JM%22">Middeke JM</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Oelschlaegel+U%22">Oelschlaegel U</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Sockel+K%22">Sockel K</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Ehninger+G%22">Ehninger G</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Serve+H%22">Serve H</searchLink>; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Baldus+CD%22">Baldus CD</searchLink>; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Röllig+C%22">Röllig C</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Bornhäuser+M%22">Bornhäuser M</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Platzbecker+U%22">Platzbecker U</searchLink>; Department of Hematology, Cellular Therapy, and Hemostaseology, University Hospital Leipzig, Leipzig, Germany; and.<br /><searchLink fieldCode="AU" term="%22Thiede+C%22">Thiede C</searchLink>; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; AgenDix GmbH, Dresden, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2022 Jun 14; Vol. 6 (11), pp. 3294-3303. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35320339 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2021006233 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3294 Titles: – TitleFull: Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stasik S – PersonEntity: Name: NameFull: Burkhard-Meier C – PersonEntity: Name: NameFull: Kramer M – PersonEntity: Name: NameFull: Middeke JM – PersonEntity: Name: NameFull: Oelschlaegel U – PersonEntity: Name: NameFull: Sockel K – PersonEntity: Name: NameFull: Ehninger G – PersonEntity: Name: NameFull: Serve H – PersonEntity: Name: NameFull: Müller-Tidow C – PersonEntity: Name: NameFull: Baldus CD – PersonEntity: Name: NameFull: Röllig C – PersonEntity: Name: NameFull: Bornhäuser M – PersonEntity: Name: NameFull: Platzbecker U – PersonEntity: Name: NameFull: Thiede C IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 06 Text: 2022 Jun 14 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 6 – Type: issue Value: 11 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |